Germanium Dioxide Nanoparticles Mitigate Biochemical and Molecular Changes Characterizing Alzheimer’s Disease in Rats

Alzheimer’s disease (AD) is a neurodegenerative disorder that jeopardizes the lives of diagnosed patients at late stages. This study aimed to assess, for the first time, the efficiency of germanium dioxide nanoparticles (GeO<sub>2</sub>NPs) in mitigating AD at the in vivo level compared...

Full description

Bibliographic Details
Main Authors: Sara A. Abdel Gaber, Amal H. Hamza, Mohamed A. Tantawy, Eman A. Toraih, Hanaa H. Ahmed
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/5/1386

Similar Items